New bladder cancer treatment rolled out by NHS - Hundreds will benefit after the first targeted treatment for the most common ...

The recommendation was based on results from the Phase III THOR trial, which compared Balversa to chemotherapy.

Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light ...

Hundreds of patients are expected to benefit from the recommendation by the National Institute of Health and Care Excellence.

The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus chemotherapy for treating resectable NSCLC ...

AstraZeneca‘s IMFINZI® (durvalumab) has gained FDA approval for use in adult patients with muscle-invasive bladder cancer ...

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...